• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING Back to Search Results
Model Number 3850
Device Problem Detachment of Device or Device Component (2907)
Patient Problems Foreign Body In Patient (2687); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/10/2023
Event Type  Injury  
Event Description
It was reported that blade detachment occurred.The 90% stenosed target lesion was located in the mildly tortuous and severely calcified proximal right coronary artery.A 6mmx2.25mm wolverine coronary cutting balloon was selected for use.During the procedure, balloon was inflated up to 12 atm and 15 dilations were made to the lesion, but sufficient inflation was not achieved.The balloon was retrieved and upon checking, all the blades had detached.Ivus was performed and the detached blade was not confirmed to be within the patient.The procedure was terminated due to sufficient dilation had not been obtained.No patient complications were reported.
 
Event Description
It was reported that blade detachment occurred.The 90% stenosed target lesion was located in the mildly tortuous and severely calcified proximal right coronary artery.A 6mmx2.25mm wolverine coronary cutting balloon was selected for use.During the procedure, balloon was inflated up to 12 atm and 15 dilations were made to the lesion, but sufficient inflation was not achieved.The balloon was retrieved and upon checking, all the blades had detached.Ivus was performed and the detached blade was not confirmed to be within the patient.The procedure was terminated due to sufficient dilation had not been obtained.No patient complications were reported.It was further reported that the blades remained inside the patient.The lesion was not sufficiently expand even though it was inflated 15 times, therefore no further treatment was performed.
 
Manufacturer Narrative
Updated h6 patient codes from no clinical signs, symptoms or conditions to foreign body in patient based on additional information received.Device evaluated by mfr: the device was returned for evaluation.A visual and microscopic examination identified that the balloon was returned in a deflated state.The balloon had been subjected to positive pressure.All 3 blades had detached from the balloon and were not returned with the device.A detailed microscopic examination confirmed that the 3 blade castpads were fully intact.All of the blade tangs were still bonded to the balloon which indicates that the blades had been securely bonded at the time of manufacture, on the balloon surface.A visual and tactile examination found no damages on the hypotube.A visual and tactile examination found no damage along the shaft polymer extrusion.No issues were noted with the tip of the device.A visual and microscopic examination found no issue with the marker bands.The device was attached to an encore inflation unit and the balloon was inflated to its rated burst pressure per ifu of 12 atmospheres.No leaks were confirmed.The inflation device verified before and after use using a druck pressure gauge.No other issues were identified during the product analysis.
 
Manufacturer Narrative
Updated h6 patient codes from no clinical signs, symptoms or conditions to foreign body in patient based on additional information received.
 
Event Description
It was reported that blade detachment occurred.The 90% stenosed target lesion was located in the mildly tortuous and severely calcified proximal right coronary artery.A 6mmx2.25mm wolverine coronary cutting balloon was selected for use.During the procedure, balloon was inflated up to 12 atm and 15 dilations were made to the lesion, but sufficient inflation was not achieved.The balloon was retrieved and upon checking, all the blades had detached.Ivus was performed and the detached blade was not confirmed to be within the patient.The procedure was terminated due to sufficient dilation had not been obtained.No patient complications were reported.It was further reported that the blades remained inside the patient.The lesion was not sufficiently expand even though it was inflated 15 times, therefore no further treatment was performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WOLVERINE CORONARY CUTTING BALLOON MONORAIL
Type of Device
CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key16247687
MDR Text Key308358162
Report Number2124215-2023-02581
Device Sequence Number1
Product Code NWX
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number3850
Device Catalogue Number3850
Device Lot Number0029942936
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/11/2023
Initial Date FDA Received01/26/2023
Supplement Dates Manufacturer Received01/30/2023
03/08/2023
Supplement Dates FDA Received02/15/2023
03/22/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/12/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-